Virbac is pleased to announce that we have completed the acquisition of SENTINEL® (milbemycin oxime/lufenuron) FLAVOR TABS® and SENTINEL® SPECTRUM® (milbemycin oxime/lufenuron/praziquantel). These two products will add even more options to our already extensive line of anti-parasitic solutions.
Learn about exclusive, no-cost resources and programs to help you build your practice and serve your patients and clients. Learn more.
Go back to school without leaving home. It's easy, convenient, and free. Earn CE credits and get the latest technical information in key treatment areas. Check out Virbac University.
We're offering your clients a rebate of up to $3 on the purchase of IVERHART MAX® (ivermectin/pyrantel pamoate/praziquantel) Chewable Tablets and IVERHART PLUS® (ivermectin/pyrantel) Flavored Chewables. Submit rebate.
Fort Worth, Texas (October 27, 2014) – Virbac Corporation today announced that it has entered into an agreement with Eli Lilly and Company to acquire major U.S. veterinary products currently marketed by Novartis Animal Health.
Good oral health starts with helping our clients understand the impact of oral disease to their animal’s health. Once the owner is aware of the importance of the situation, the veterinary team must…Read more…
If you share our passion for animal health, we invite you to explore opportunities to bring your talent to Virbac.